CYPSX
Price
$42.93
Change
-$2.98 (-6.49%)
Updated
Apr 4 closing price
Net Assets
24.8M
RYCCX
Price
$255.98
Change
-$35.68 (-12.23%)
Updated
Apr 4 closing price
Net Assets
646.85M
Ad is loading...

CYPSX vs RYCCX

Header iconCYPSX vs RYCCX Comparison
Open Charts CYPSX vs RYCCXBanner chart's image
ProFunds Consumer Disctnry Ultra Sec Svc
Price$42.93
Change-$2.98 (-6.49%)
VolumeN/A
Net Assets24.8M
Rydex NASDAQ-100® 2x Strategy C
Price$255.98
Change-$35.68 (-12.23%)
VolumeN/A
Net Assets646.85M
CYPSX vs RYCCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CYPSX vs. RYCCX commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYPSX is a Hold and RYCCX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RYCCX has more cash in the bank: 647M vs. CYPSX (24.8M). CYPSX (0.00) and RYCCX (0.00) have matching dividends . CYPSX was incepted earlier than RYCCX: CYPSX (21 years) vs RYCCX (24 years). RYCCX (2.75) and CYPSX (2.62) have similar cost to investors . RYCCX is a more actively managed with annual turnover of: 392.00 vs. CYPSX (173.00). RYCCX has a lower initial minimum investment than CYPSX: RYCCX (2500) vs CYPSX (15000). CYPSX annual gain was more profitable for investors over the last year : 5.25 vs. RYCCX (-10.59). RYCCX return over 5 years is better than : 185.07 vs. CYPSX (67.19).
CYPSXRYCCXCYPSX / RYCCX
Total Expense Ratio2.622.6599%
Annual Report Gross Expense Ratio2.622.7595%
Fund Existence21 years24 years-
Gain YTD-22.502-24.66991%
Front LoadN/AN/A-
Min. Initial Investment150002500600%
Min. Initial Investment IRA15000N/A-
Net Assets24.8M647M4%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.25-10.59-50%
Returns for 3 years-5.143.28-157%
Returns for 5 years67.19185.0736%
Returns for 10 years80.44359.5522%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMUSX22.02N/A
N/A
Franklin U.S. Large Cap Equity FI
TSCSX27.45N/A
N/A
Thrivent Small Cap Stock S
MWOIX60.26N/A
N/A
MFS Global Growth I
AHSZX19.06N/A
N/A
Alger Health Sciences Z
TRZAX45.49N/A
N/A
T. Rowe Price Value Z